Sichuan Biokin Pharmaceutical Co.,Ltd.

¥264.60As of Sun 8 Nov 2026, 12:00 UTC
SSE:688506Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR 44.82%
Div yield —
ROE (20.01%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.02)
PE TTM —
TSR TTM (29.06%)
Mkt cap ¥108.8B
ROIC (33.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥307
16.17%
21.41%
Hold 9|7|3|1|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
2.53
2.68
2.76
2.79
12.28%
19.01%
19.76%
20.99%
Revenue¥B
7.429
7.495
7.888
7.956
9.22%
6.14%
5.54%
9.25%
Peers (US$16.31B)
Cap (US$)
PE
14.75B
18.94x
8.673B
17.73x
16.11B
10.50x
Capital
TTM
5Y
10Y
Leveragex
1.308
0.361
0.249
EBIT/Intx
1.839
0.998
0.819
Own earn%
24.31
(74.96)
(58.02)
Sh yield%
41.64
20.13
21.97
Owners
Insiders/Inst%
13.59
65.20
Short interest%
1.61
SBC / revenue%
4.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
22–30
$1 testx
0.0
Incr. ROIC%
1